The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages S33-S40

  Rodriguez Rodriguez, Luis ^a   Lamas, Jose Ramón ^a   Abásolo, Lydia ^a   Baena, Sara ^a   Olano Martin, Estíbaliz ^b   Collado, Antonio ^c   Rivera, Javier ^d   Fernández Gutiérrez, Benjamín ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Progenika Biopharma SA ^*  (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Fibromyalgia; rs3771863; Sicca syndrome; Single nucleotide polymorphism; TACR1

Indexed keywords

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTITIS; DEPRESSION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEADACHE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; MYOFASCIAL PAIN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SLEEP DISORDER; SYNDROME; SYNDROME DELINEATION; TACHYKININ RECEPTOR 1 GENE; VERTIGINOUS SYNDROME; COMORBIDITY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PHENOTYPE; PROCEDURES; PROTECTION; QUESTIONNAIRE; RISK; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SPAIN;

NEUROKININ 1 RECEPTOR;

ADULT; COMORBIDITY; FEMALE; FIBROMYALGIA; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE FACTORS; QUESTIONNAIRES; RECEPTORS, NEUROKININ-1; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SPAIN;

EID: 84929294552     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. BENNETT RM, JONES J, TURK DC et al.: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007; 8: 27.
2. GIACOMELLI C, SERNISSI F, SARZI-PUTTINI P, Di FRANCO M, ATZENI F, BAZZICHI L: Fibromyalgia: a critical digest of the recent literature. Clin Exp Rheumatol 2013; 31(Suppl. 79): S153-7.
3. HUDSON JI, ARNOLD LM, KECK PE Jr, AUCHENBACH MB, POPE HG Jr.: Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004; 56: 884-91.
4. ARNOLD LM, HUDSON JI, HESS EV et al.: Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944-52.
5. HUDSON JI, MANGWETH B, POPE HG et al.: Family study of affective spectrum disorder. Arch Gen Psychiatry 2003; 60: 170-7.
6. BRADLEY LA: Pathophysiology of fibro-myalgia. Am J Med 2009; 122: S22-30.
7. BUSKILA D, NEUMANN L, HAZANOV I, CARMI R.: Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996; 26: 605-11.
8. KATO K, SULLIVAN PF, EVENGÅRD B, PEDERSEN NL: Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 2006; 166: 1649-54.
9. KATO K, SULLIVAN PF, EVENGÅRD B, PEDERSEN NL: Importance of genetic influences on chronic widespread pain. Arthritis Rheum 2006; 54: 1682-6.
10. MARKKULA R, JÄRVINEN P, LEINO-ARJAS P, KOSKENVUO M, KALSO E, KAPRIO J: Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain 2009; 13: 744-50.
11. POTVIN S, LAROUCHE A, NORMAND E et al.: DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 2009; 10: 969-75.
12. VARGAS-ALARCÓN G, FRAGOSO J-M, CRUZ-ROBLES D et al.: Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 2007; 9: R110.
13. NICHOLL BI, HOLLIDAY KL, MACFARLANE GJ et al.: Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts. Arthritis Rheum 2011; 63: 810-8.
14. BONDY B, SPAETH M, OFFENBAECHER M et al.: The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999; 6: 433-9.
15. HOLLIDAY KL, NICHOLL BI, MACFARLANE GJ et al.: Genetic variation in the hypothalamic-pituitary-adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study. Ann Rheum Dis 2010; 69: 556-60.
16. VARGAS-ALARCÓN G, FRAGOSO J-M, CRUZROBLES D et al.: Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains. Arthritis Rheum 2009; 60: 2169-73.
17. HOLLIDAY KL, NICHOLL BI, MACFARLANE GJ et al.: Do genetic predictors of pain sensitivity associate with persistent widespread pain? Mol Pain 2009; 5: 56.
18. VARGAS-ALARCON G, ALVAREZ-LEON E, FRAGOSO J-M et al.: A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord 2012; 13: 23.
19. SU S-Y, CHEN JJ-H, LAI C-C et al.: The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol 2007; 26: 12-6.
20. YIGIT S, INANIR A, TEKCAN A et al.: Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population. Gene 2013;.
21. ALASEHIRLI B, DEMIRYÜREK S, ARICA E et al.: No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. Rheumatol Int 2007; 27: 275-80.
22. SMITH SB, MAIXNER DW, FILLINGIM RB et al.: Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 2012; 64: 584-93.
23. ARNOLD LM, FAN J, RUSSELL IJ et al.: The fibromyalgia family study: a genomewide linkage scan study. Arthritis Rheum 2013; 65: 1122-8.
24. DOCAMPO E, ESCARAMÍS G, GRATACÒS M et al.: Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system. Pain 2014; 155: 1102-9.
25. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
26. FUKUDA K, STRAUS SE, HICKIE I et al.: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-9.
27. SPAETH M, RIZZI M, SARZI-PUTTINI P: Fibromyalgia and sleep. Best Pract Res Clin Rheumatol 2011; 25: 227-39.
28. GERWIN RD: A review of myofascial pain and fibromyalgia--factors that promote their persistence. Acupunct Med 2005; 23: 121-34.
29. FORD AC, BERCIK P, MORGAN DG, BOLINO C, PINTOS-SANCHEZ MI, MOAYYEDI P: Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Gastroenterology 2013;.
30. BOGART LM, BERRY SH, CLEMENS JQ: Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 2007; 177: 450-6.
31. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
32. RIVERA J, GONZÁLEZ T: The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004; 22: 554-60.
33. HERRERO MJ, BLANCH J, PERI JM, DE PABLO J, PINTOR L, BULBENA A: A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 2003; 25: 277-83.
34. JOHNSON AD, HANDSAKER RE, PULIT SL, NIZZARI MM, O'DONNELL CJ, DE BAKKER PI: SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008; 24: 2938-9.
35. NYHOLT DR: A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-9.
36. SKOL AD, SCOTT LJ, ABECASIS GR, BOEHNKE M: Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209-13.
37. PURCELL S, NEALE B, TODD-BROWN K et al.: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
38. MÄGI R, MORRIS AP: GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 2010; 11: 288.
39. DINERMAN H, GOLDENBERG DL, FELSON DT: A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986; 13: 368-73.
40. CHAMPEY J, CORRUBLE E, GOTTENBERG J-E et al.: Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006; 55: 451-7.
41. NEWTON JL, FRITH J, POWELL D et al.: Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome. Ann Rheum Dis 2012; 71: 1973-9.
42. MARTÍNEZ-LAVÍN M, HERMOSILLO AG: Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 2000; 29: 197-9.
43. PENNEFATHER JN, LECCI A, CANDENAS ML et al.: Tachykinins and tachykinin receptors: a growing family. Life Sci 2004; 74: 1445-63.
44. SEVERINI C, IMPROTA G, FALCONIERIERSPAMER G et al.: The tachykinin peptide family. Pharmacol Rev 2002; 54: 285-322.
45. PATACCHINI R, LECCI A, HOLZER P et al.: Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci. 2004; 25: 1-3.
46. SENEVIRATNE C1, AIT-DAOUD N, MA JZ, CHEN G, JOHNSON BA, LI MD: Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence Neuropsychopharmacology 2009; 34: 2442-9.
47. BLAINE S, CLAUS E, HARLAAR N, HUTCHISON K: TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol Clin Exp Res 2013; 37 (Suppl. 1): E125-30.
48. PERLIS RH, PURCELL S, FAGERNESS J et al.: Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry 2008; 65: 53-61.
49. YAN TC, McQUILLIN A, THAPAR A et al.: NK1(TACR1) receptor gene "knockout" mouse phenotype predicts genetic association with ADHD. J Psychopharmacol 2010; 24: 27-38.
50. ABLIN JN, BAR-SHIRA A, YARON M, ORRURTREGER A: Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin. Clin Exp Rheumatol 2009; 27 Suppl. 56): S33-8.
51. RENNER SP, EKICI AB, MAIHÖFNER C et al.: Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosis. Gynecol Endocrinol 2009; 25: 726-33.
52. GARCIA-BARCELO M, KING SK, MIAO X et al.: Application of HapMap data to the evaluation of 8 candidate genes for pediatric slow transit constipation. J Pediatr Surg 2007; 42: 666-71.
53. BOYLE AP, HONG EL, HARIHARAN M et al.: Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012; 22: 1790-7.
54. WESTRA H-J, PETERS MJ, ESKO T et al.: Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013; 45: 1238-43.
55. KOZOMARA A, GRIFFITHS-JONES S: miR-Base: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-7.
56. TULUC F, LAI JP, KILPATRICK LE, EVANS DL, DOUGLAS SD: Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol 2009; 30: 271-6.
57. MANCHIA M, CULLIS J, TURECKI G, ROULEAU GA, UHER R, ALDA M: The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases. PLoS One 2013; 8: e76295.